Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

2022studies shown

Showing 601-625 of 2,022

RecruitingISRCTN62599190

Comparison of training methods in dual diagnosis (mental health and substance use) treatment for community mental health teams

This study is looking at whether This is an intention to treat, repeated measure within subjects randomised trial can help people with Schizophrenia, co-morbid drug and alcohol dependence, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherOver 18 Years

Countries: United Kingdom
Sponsor: University College London (UK)
Condition: Schizophrenia

RecruitingISRCTN23263429

Efficacy of the BELA weight management programme to prevent increase of weight in schizophrenic patients treated with olanzapin (BELA = movement - nutrition - learning - accepting)

This study is looking at whether psychoeducation can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in psychoeducation and complete follow-up assessments.

SchizophreniaOtherOver 18 Years

Countries: Germany
Sponsor: Heinrich-Heine University (Germany)
Condition: Schizophrenia

RecruitingISRCTN33909010

A phase 3 randomised placebo- and active comparator-controlled, clinical trial to study the safety and efficacy of two doses of lurasidone HCL in acutely psychotic patients with schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years

Countries: United Kingdom, Bulgaria, Colombia, India, Lithuania, Peru, Philippines, Serbia
Sponsor: Dainippon Sumitomo Pharma America Inc. (USA)
Condition: Schizophrenia

RecruitingISRCTN16838597

A phase three randomised, placebo-controlled, clinical trial to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic patients with schizophrenia

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years

Countries: United Kingdom, France, India, Malaysia, Romania, Russian Federation, Ukraine, United States
Sponsor: Dainippon Sumitomo Pharma America Inc. (USA)
Condition: Schizophrenia

RecruitingISRCTN97049967

Phase 3 long-term safety, tolerability and effectiveness of lurasidone in subjects with schizophrenia or schizoaffective disorder

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 75 Years

Countries: United Kingdom, Argentina, Brazil, Chile, Croatia, Israel, South Africa, Thailand
Sponsor: Dainippon Sumitomo Pharma America Inc. (USA)
Condition: Schizophrenia

RecruitingISRCTN02658871

Secondary PREVENTion of schizophrenia: a randomised controlled trial

This study is looking at whether psychoeducation can help people with Prodromal schizophrenia, Mental and Behavioural Disorders, or Schizotypal disorder. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 49 Years

Countries: Germany
Sponsor: University of Cologne (Germany)
Condition: Schizophrenia

RecruitingISRCTN93378085

Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulation

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Some participants may receive sham treatment instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 55 Years

Countries: United Kingdom
Sponsor: Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Condition: Schizophrenia

RecruitingISRCTN19638644

How can rehospitalisations of patients with schizophrenia be avoided? A comparison between different compliance programs

This study is looking at whether psychoeducation can help people with Schizophrenia or schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, schizotypal and delusional disorders. Participants take part in psychoeducation and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 67 Years

Countries: Germany
Sponsor: Technical University Munich (Germany)
Condition: Schizophrenia

RecruitingISRCTN95205723

Metacognitive skill training for schizophrenic patients

This study is looking at whether Experimental intervention: MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Experimental intervention: MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia and complete follow-up assessments.

SchizophreniaOther

Countries: Germany
Sponsor: German Research Foundation (DFG)/Federal Ministry of Education and Research (BMBF) (Germany)
Condition: Schizophrenia

RecruitingISRCTN29242879

Cognitive behavioural treatment for persistent positive symptoms in psychotic disorders

This study is looking at whether Cognitive Behavioural Treatment versus Supportive Therapy can help people with psychosis or Mental and Behavioural Disorders. Participants take part in Cognitive Behavioural Treatment versus Supportive Therapy and complete follow-up assessments.

SchizophreniaOther

Countries: Germany
Sponsor: University Hospital Tuebingen (Germany)
Condition: Schizophrenia

RecruitingISRCTN02457313

The effectiveness of support groups for people suffering from psychosis: a randomised controlled trial

This study is looking at care and outcomes for people with Schizophrenia, Psychosis, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

SchizophreniaOtherOver 18 Years

Countries: Netherlands
Sponsor: University Medical Center Groningen (UMCG) (The Netherlands)
Condition: Schizophrenia

RecruitingISRCTN65536352

Cognitive Behavioural Case Management (CBCM) in First-Episode Schizophrenia and Related Psychotic Disorders - a pilot study

This study is looking at whether [A] Cognitive Behavioural Case Management [B] Treatment-as-usual can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in [A] Cognitive Behavioural Case Management [B] Treatment-as-usual and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Condition: Schizophrenia

RecruitingISRCTN11138647

Relapse Prevention Group Programme for service users with an international statistical classification of diseases and related health problems (ICD10, chapter F20) diagnosis of schizophrenia in a community setting - a randomised controlled trial

This study is looking at whether Relapse prevention programme as opposed to treatment as usual can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Relapse prevention programme as opposed to treatment as usual and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 45 Years

Countries: United Kingdom
Sponsor: Brent Mental Health Service (UK)
Condition: Schizophrenia

RecruitingISRCTN46150447

Interactive group art therapy as an adjunctive treatment for people with schizophrenia

This study is looking at whether The trial has three arms can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in The trial has three arms and complete follow-up assessments.

SchizophreniaOtherOver 18 Years

Countries: United Kingdom
Sponsor: Imperial College London (UK)
Condition: Schizophrenia

RecruitingISRCTN00721331

Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phase

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: Finland
Sponsor: Stanley Medical Research Institute (USA)
Condition: Schizophrenia

RecruitingISRCTN75187865

Cognitive remediation for young people with schizophrenia

This study is looking at whether Cognitive remediation therapy versus usual care can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive remediation therapy versus usual care and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: King's College London (UK)
Condition: Schizophrenia

RecruitingISRCTN46561083

Reasoning and rehabilitation in mentally disordered offenders: a pilot randomised controlled trial

This study is looking at whether Reasoning and rehabilitation programme versus treatment as usual can help people with Schizophrenia or schizoaffective disorder or Mental and Behavioural Disorders. Participants take part in Reasoning and rehabilitation programme versus treatment as usual and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: The Institute of Psychiatry (UK)
Condition: Schizophrenia

RecruitingISRCTN74277581

Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand: a randomised controlled trial

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther

Countries: United Kingdom, Thailand
Sponsor: The Royal Thai Government
Condition: Schizophrenia

RecruitingISRCTN61441186

Open, randomised trial of the effect of aripiprazole versus risperidone on social cognition in schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to 80 schizophrenia patients are randomly assigned to either risperidone (4 mg) or aripiprazole (15 mg), but direct benefit is not guaranteed.

SchizophreniaOtherOver 18 Years

Countries: Netherlands
Sponsor: University Medical Centre Utrecht (UMCU) (The Netherlands)
Condition: Schizophrenia

RecruitingISRCTN17350364

Prodromal symptoms and early intervention to prevent a relapse

This study is looking at a support or therapy approach for people with Schizophrenia, Schizophreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOther

Countries: Netherlands
Sponsor: Mental Health Care Services Drenthe (Netherlands)
Condition: Schizophrenia

RecruitingISRCTN27750123

Efficacy and tolerability of ziprasidone versus clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and cannabis use disorder: a randomised study

This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to Patients will be randomised to either the ziprasidone or clozapine group, but direct benefit is not guaranteed.

SchizophreniaOther

Countries: Germany
Sponsor: University of Cologne (Germany)
Condition: Schizophrenia

RecruitingISRCTN06332944

Schizophrenia Termination Of Pharmacotherapy: STOP-trial

This study is looking at whether 1 can help people with Schizophrenia, schizophreniform disorder, schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther

Countries: Netherlands
Sponsor: The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Condition: Schizophrenia

RecruitingISRCTN57292778

Cost-effectiveness of cognitive behaviour therapy of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis.

This study is looking at whether Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008 can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008 and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 64 Years

Countries: Netherlands
Sponsor: University Medical Center Groningen (Netherlands)
Condition: Schizophrenia

RecruitingISRCTN16228411

Medication strategies in first onset schizophrenia (Mesifos)

This study is looking at whether Maintenance treatment was carried out according to the guidelines of the APA can help people with Non affective psychosis, schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 45 Years

Countries: Netherlands
Sponsor: University Medical Centre Groningen (UMCG) (Netherlands)
Condition: Schizophrenia

RecruitingISRCTN25455020

Cognitive behavioural treatment of negative symptoms in patients with schizophrenic disorders

This study is looking at whether Cognitive Behavioural Treatment versus Cognitive Remediation can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive Behavioural Treatment versus Cognitive Remediation and complete follow-up assessments.

SchizophreniaOther

Countries: Germany
Sponsor: University Hospital Tuebingen (Germany)
Condition: Schizophrenia

Schizophrenia | Clinical Trials | HopeStage Research